Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

By J. Peiris, C. Chu, V. Cheng, Ks Chan, I. Hung, L. Poon, K. Law, B. Tang, T. Hon, C. Chan and 7 more. The Lancet, 2003

2,385 citations recorded by the source corpus.

Summary Background We investigated the temporal progression of the clinical, radiological, and virological changes in a community outbreak of severe acute respiratory syndrome (SARS). Methods We followed up 75 patients for 3 weeks managed with a standard treatment protocol of ribavirin and corticosteroids, and assessed the pattern of clinical disease, viral load, risk factors for poor clinical outcome, and the usefulness of virological diagnostic methods. Findings Fever and pneumonia initially improved but 64 (85%) patients developed recurrent fever after a mean of 8.9 (SD 3.1) days, 55 (73%) had watery diarrhoea after 7.5 (2.3) days, 60 (80%) had radiological worsening after 7.4 (2.2) days, and respiratory symptoms worsened in 34 (45%) after 8.6 (3.0) days. In 34 (45%) patients, improvement of initial pulmonary lesions was associated with appearance of new radiological lesions at other sites. Nine (12%) patients developed spontaneous pneumomediastinum and 15 (20%) developed acute respiratory distress syndrome (ARDS) in week 3. Quantitative reverse-transcriptase (RT) PCR of nasopharyngeal aspirates in 14 patients (four with ARDS) showed peak viral load at day 10, and at day 15 a load lower than at admission. Age and chronic hepatitis B virus infection treated with lamivudine were independent significant risk factors for progression to ARDS (p=0.001). SARS-associated coronavirus in faeces was seen on RT-PCR in 65 (97%) of 67 patients at day 14. The mean time to seroconversion was 20 days. Interpretation The consistent clinical progression, shifting radiological infiltrates, and an inverted V viral-load profile suggest that worsening in week 2 is unrelated to uncontrolled viral replication but may be related to immunopathological damage. Published online May 9, 2003 http://image.thelancet.com/extras/03art4432web.pdf

Subfields: Epidemiology, Infectious Diseases, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/a6f1a703194e8a959fef81aac5d26499a3dadf1e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

In Infectious Diseases

In Pulmonary and Respiratory Medicine

Citations in the corpus

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis (2004, background): “Active viral replication in the enterocytes of the small intestine has been reported by Leung et al [20] and SARS-CoV RNA can be detected in patients’ stool samples [16,17,20].”
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study (2020, background): “We considered periods where the mean infectious day is less than 15 days after symptom onset (roughly the period of SARS and early SARS-CoV-2 reports 16, 17 ) , and assumed that R=2·6 and that isolation effectively ends the infectious period.”
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series (2020, background): “Most of the patients (17) also had hypotension and needed vasopressors.”
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China (2020, neutral): “And in Guan's study, 35 .8% (393/1099) of patients received oseltamivir [85] .”
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings (2004, background): “5 We hypothesise that the immunopathological response is triggered by the viral antigen; the most strategic treatment is therefore to stop the viral replication at the beginning so that the peak viral load and the subsequent immunopathological damage will be minimised.”
Competing Interests: The authors (2006, positive): “Firstly, MS-based analysis has high sensitivity, providing successful detection of virus more than 95% of the time at virus concentrations as low as 75 RNA copies per reaction (equivalent to a detection sensitivity of 10(3)–10(4) RNA copies per milliliter), which is close to the detection limit of r”
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system (2020, neutral): “Since the first reports of SARS, it seemed clear that the severe clinical manifestations of the disease could not be ascribed only to the viral activity per se, but that an immune-mediated mechanism rather than a direct virus-induced damage would drive the clinical progression [67] .”
Mechanisms and enzymes involved in SARS coronavirus genome expression. (2003, background): “There is now clear evidence that SARS is caused by a previously unknown coronavirus, provisionally termed SARS coronavirus (SARS-CoV) (Peiris et al., 2003b; Drosten et al., 2003; Ksiazek et al., 2003; Fouchier et al., 2003).”
Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection (2007, background): “spontaneous pneumomediastinum may occur (74, 258).”